A Multicentre, Prospective, Non‐Interventional Single‐Arm Study Investigating the Impact of Once‐Daily Oral Semaglutide in a Real‐World Adult Population With Type 2 Diabetes in Mexico

Documenti analoghi

• Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis
  di: Ali Abdullah, et al.
  Pubblicazione: (2025)
• Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
  di: Obieda Altobaishat, et al.
  Pubblicazione: (2025)
• Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
  di: Mushood Ahmed, et al.
  Pubblicazione: (2024)
• Determination of the Optimal Cut‐Off Point of Anthropometric Indices to Predict the Risk of Metabolic Syndrome in Iranian Adult Population With Type 2 Diabetes Mellitus: A Cross‐Sectional‐Analytical Study
  di: Mohammad Moqaddasi Amiri, et al.
  Pubblicazione: (2026)
• Identification of Risk Factors for the Development of Diabetic Retinopathy Among Palestinian Adults With Type 2 Diabetes Mellitus: A Cross‐Sectional Study
  di: Oadi N. Shrateh, et al.
  Pubblicazione: (2024)